4.5 Article

Osteopontin: a novel inflammatory mediator of cardiovascular disease

期刊

FRONTIERS IN BIOSCIENCE-LANDMARK
卷 12, 期 -, 页码 214-221

出版社

FRONTIERS IN BIOSCIENCE INC
DOI: 10.2741/2059

关键词

osteopontin; vascular inflammation; myocardial infarction; left ventricular hypertrophy; myocardial remodeling; coronary artery disease; valvular calcification

资金

  1. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057947, R01HL071519, R01HL063070] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI043310] Funding Source: NIH RePORTER
  3. NHLBI NIH HHS [HL-63070, HL-057947, R01 HL071519, HL-071519] Funding Source: Medline
  4. NIAID NIH HHS [AI-43310] Funding Source: Medline

向作者/读者索取更多资源

Osteopontin, also called cytokine Eta- 1, is a multifunctional protein containing Arg- Gly- Asp- Ser ( RGDS) cell- binding sequence. It interacts with alpha v beta 1, alpha v beta 3 and alpha v beta 5 integrins and CD44 receptors. OPN is suggested to play a role during inflammation via the recruitment and retention of macrophages and T-cells to inflamed sites. OPN regulates the production of inflammatory cytokines and nitric oxide in macrophages. In this review, we will discuss diverse roles of OPN related to cardiovascular diseases, including atherosclerosis, valvular stenosis, hypertrophy, myocardial infarction and heart failure.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据